Why the Susan G. Komen for the Cure Foundation’s previously unassailable brand in healthcare fundraising may have sustained some permanent damage.
Chris Guiffre, SVP and Chief Business Officer, Cerulean Pharmaceuticals
P&G has historically spent 9%-11% on advertising, but the company is looking for corners to cut and finding them in social media.
Researchers are sensing a waning influence within their companies
Consumer work that creatively breaks the healthcare barriers and, most importantly, drives customers to act
Weary of FDA foot-dragging on digital and social media guidance for pharmas, a group of industry digerati put together guidelines of their own.
Jeff Arnold, co-founder, chairman and CEO, Sharecare
What happens when a celebrity goes off message, gets a DUI or is photographed eating a hamburger?
Missing documents allegedly kept a review of Tamiflu from conclusively examining the drug’s efficacy. Are reviews marred by publication and reporting biases? What can be done to make assessments more robust?
It was a night to remember as the stars of medical advertising came out to welcome three more legends into the Hall of Fame
Get to know each of these companies by learning about their culture, work/life balance, D&I initiatives and more.
OptimizeRx’s Chris DiCostanzo and Rebecca Love explain the value of reaching patients and HCPs when it matters most.
Talking Medicines’ Jo Halliday discussed how the pharmaceutical sector can better understand the voice of the patient.
Learn about Intouch Group’s journey to foster I+D so that its inclusive culture translates into inclusive healthcare marketing.
Any EHR provider delivering a quality solution should be able to answer these six questions.
Please login or register first to view this content.